94 related articles for article (PubMed ID: 7529851)
1. Usefulness of platelet-derived growth factor as a prognostic factor in pulmonary adenocarcinoma.
Takanami I; Imamura T; Yamamoto Y; Kodaira S
J Surg Oncol; 1995 Jan; 58(1):40-3. PubMed ID: 7529851
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-II as a prognostic factor in pulmonary adenocarcinoma.
Takanami I; Imamuma T; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
J Surg Oncol; 1996 Mar; 61(3):205-8. PubMed ID: 8637208
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 as a prognostic factor in pulmonary adenocarcinoma.
Takanami I; Imamura T; Hashizume T; Kikuchi K; Yamamoto Y; Kodaira S
J Clin Pathol; 1994 Dec; 47(12):1098-100. PubMed ID: 7876382
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
[TBL] [Abstract][Full Text] [Related]
5. Expression of PDGF, IGF-II, bFGF and TGF-beta 1 in pulmonary adenocarcinoma.
Takanami I; Imamuma T; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
Pathol Res Pract; 1996 Nov; 192(11):1113-20. PubMed ID: 9122030
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry analysis of platelet-derived growth factor A and B chains and platelet-derived growth factor alpha and beta receptor expression in benign prostatic hyperplasias and Gleason-graded human prostate adenocarcinomas.
Fudge K; Wang CY; Stearns ME
Mod Pathol; 1994 Jun; 7(5):549-54. PubMed ID: 7524068
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of platelet-derived growth factor-A (PDGF-A) in gastric carcinoma.
Katano M; Nakamura M; Fujimoto K; Miyazaki K; Morisaki T
Ann Surg; 1998 Mar; 227(3):365-71. PubMed ID: 9527059
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
10. Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer.
Seymour L; Dajee D; Bezwoda WR
Breast Cancer Res Treat; 1993; 26(3):247-52. PubMed ID: 8251649
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor A and B chains and the alpha and beta receptors in prostatic intraepithelial neoplasia.
Fudge K; Bostwick DG; Stearns ME
Prostate; 1996 Nov; 29(5):282-6. PubMed ID: 8899000
[TBL] [Abstract][Full Text] [Related]
12. Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma.
Zhong Y; Jiang L; Lin H; Li B; Lan J; Liang S; Shen B; Lei Z; Zheng W
Diagn Pathol; 2015 Jul; 10():101. PubMed ID: 26168791
[TBL] [Abstract][Full Text] [Related]
13. Expression in lung carcinomas of platelet-derived growth factor and its receptors.
Kawai T; Hiroi S; Torikata C
Lab Invest; 1997 Nov; 77(5):431-6. PubMed ID: 9389786
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of vascular endothelial growth factor (VEGF), VEGF receptor 2, platelet-derived growth factor-β (PDGF-β), and PDGF-β receptor expression in papillary renal cell carcinoma.
Kim M; Sohn M; Shim M; Choi SK; Park M; Kim E; Go H; Park Y; Cho YM; Ro JY; Jeong IG; Song C; Hong JH; Kim CS; Ahn H
Hum Pathol; 2017 Mar; 61():78-89. PubMed ID: 27989785
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors.
Palman C; Bowen-Pope DF; Brooks JJ
Lab Invest; 1992 Jan; 66(1):108-15. PubMed ID: 1309926
[TBL] [Abstract][Full Text] [Related]
16. The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer.
Vignaud JM; Marie B; Klein N; Plénat F; Pech M; Borrelly J; Martinet N; Duprez A; Martinet Y
Cancer Res; 1994 Oct; 54(20):5455-63. PubMed ID: 7923179
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.
Andersen S; Donnem T; Al-Saad S; Al-Shibli K; Busund LT; Bremnes RM
J Thorac Oncol; 2009 Apr; 4(4):463-71. PubMed ID: 19204576
[TBL] [Abstract][Full Text] [Related]
18. Serum PDGF-AB in pleural mesothelioma.
Filiberti R; Marroni P; Neri M; Ardizzoni A; Betta PG; Cafferata MA; Canessa PA; Puntoni R; Ivaldi GP; Paganuzzi M
Tumour Biol; 2005; 26(5):221-6. PubMed ID: 16103743
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of basic fibroblast growth factor as a prognostic indicator in pulmonary adenocarcinoma.
Takanami I; Imamura T; Hashizume T; Kikuchi K; Yamamoto Y; Yamamoto T; Kodaira S
Jpn J Clin Oncol; 1996 Oct; 26(5):293-7. PubMed ID: 8895667
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implication of transforming growth factor alpha in adenocarcinoma of the lung--an immunohistochemical study.
Tateishi M; Ishida T; Mitsudomi T; Sugimachi K
Br J Cancer; 1991 Jan; 63(1):130-3. PubMed ID: 1989651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
